Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights

Go back to Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
(NASDAQ: XERS) Delayed: 6.95 --0 (-0%)
Previous Close $6.95    52 Week High
Open $6.95    52 Week Low
Day High $6.95    P/E N/A 
Day Low $6.95    EPS
Volume 2,999